Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.36 |
| ▸ | IDO1 | P14902 | 3/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18251983 | 0.87 | — | — | |
| SCHEMBL18032161 | 0.79 | — | — | |
| SCHEMBL18252110 | 0.79 | — | — | |
| SCHEMBL6663497 | 0.77 | MAOB (0.37) | HTR2CIDO1SPHK1TAAR1 | |
| SCHEMBL15460685 | 0.77 | — | — | |
| SCHEMBL18252052 | 0.77 | — | — | |
| SCHEMBL18032159 | 0.77 | SPHK1 (0.43) | HTR2CSPHK1 | |
| SCHEMBL6664938 | 0.76 | ALDH1A1 (0.32) | SPHK1 | |
| SCHEMBL18251989 | 0.76 | — | — | |
| SCHEMBL6666538 | 0.75 | SPHK1 (0.30) | SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9777219-B2 | Liquid crystal compound having tetracycle, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| US-9777219-B2 | Liquid crystal compound having tetracycle, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20160340584-A1 | LIQUID CRYSTAL COMPOUND HAVING TETRACYCLE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
| US-20160340584-A1 | LIQUID CRYSTAL COMPOUND HAVING TETRACYCLE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160340584-A1 | LIQUID CRYSTAL COMPOUND HAVING TETRACYCLE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | TCOF1, CALCOCO2, ZKSCAN2 | HTR2C 609/4885IDO1 1732/4885CNR1 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.